Tiziana La Bella

Employment

• Généthon post-doc
  2019 - Present
• INSERM
  2015 - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness.
  Molecular therapy. Methods & clinical development 2024 DOI: 10.1016/j.omtm.2024.101327
  +Save
• A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III
  The Journal of clinical investigation 2023 DOI: 10.1172/JCI172018
  +Save
• Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
  Gut 2021 DOI: 10.1136/gutjnl-2020-323153
  +Save
• Adeno-associated virus in the liver: natural history and consequences in tumour development.
  Gut 2019 DOI: 10.1136/gutjnl-2019-318281
  +Save
• Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
  Gastroenterology 2019 DOI: 10.1053/j.gastro.2019.05.001
  +Save
• Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
  Nature Communications 2018 DOI: 10.1038/s41467-018-07552-9
  +Save
• Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro
  Clinical Cancer Research 2017 DOI: 10.1158/1078-0432.ccr-16-3118
  +Save
• In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis
  Clinical Cancer Research 2017 DOI: 10.1158/1078-0432.ccr-16-1464
  +Save
• Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV
  Molecular Therapy 2016 DOI: 10.1038/mt.2016.47
  +Save